Amazfit Introduces Balance 2 Smartwatch and Helio Strap for Smarter Training, Better Recovery and Peak Performance
24.6.2025 16:00:00 EEST | Business Wire | Press release
Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), a health technology company, today announced the launch and availability of two new performance-focused devices—the Balance 2 smartwatch and the Helio Strap, Amazfit’s first screen-free fitness, recovery, and sleep tracker.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250624910772/en/
Amazfit Introduces Balance 2 Smartwatch and Helio Strap
Better Together: A Smarter Training and Recovery System
While both devices can be purchased and used individually, it's their combined potential as an all-in-one training and recovery system that truly sets them apart. Balance 2 is a premium multisport training partner that gives users access to advanced performance tracking. When paired with the Helio Strap, the system delivers even greater accuracy in heart rate monitoring, fatigue assessment, and recovery analysis. All data syncs effortlessly within the Zepp App, providing a unified ecosystem and experience across all Amazfit devices—no additional apps or subscriptions required.
Balance 2: The Premium Multisport Training Partner
Built for high performers, the new Amazfit Balance 2 supports daily training across multiple sports — perfect for hybrid athletes and anyone balancing gym workouts, strength training, running, cycling, golf, diving, and more. With intelligent tracking, personalized insights, and a design that transitions effortlessly from intense training sessions to workdays and weekend outings, Balance 2 empowers users to excel in every moment. ($299.99 USD; €299.9 euro)
Key Features:
○ Durability and Performance: Scratch-resistant 1.5-inch Sapphire glass screen with an AMOLED display and up to 2000 nits of brightness for excellent visibility in any lighting and sustained performance, plus 10 ATM water resistance and 21-day battery life.
○ HYROX-Optimized Training: As the Official Timekeeper of HYROX, Amazfit is the first—and only—brand with three dedicated HYROX modes. Specifically designed to support the demands of structured HYROX workouts, it lets users plan intervals, heart rate zones, transitions, and recovery—then track and analyze it all in the Zepp App for smarter performance and faster recovery.
○ Enhanced Monitoring: More accurate monitoring of key biometrics, including exercise heart rate, HRV, blood oxygen level, sleep patterns and more.
○ Free Downloadable Maps ideal for both city running and weekend adventures.
○ Advanced Golf Features: Amazfit’s first smartwatch with a full in-round golf experience—40K+ course maps, pin relocation, hazards, scoring, and swing feedback like swing plane and tempo. With golf now built in, Balance 2 is an all-in-one watch for work, workouts, and the course—no separate golf watch needed.
○ Dedicated Diving Support: With 100-meter water resistance, Balance 2 supports both freediving and scuba diving up to 45 meters, enabling accurate tracking and enhanced safety for underwater performance.
○ 170+ Sport Modes, including running, swimming, strength training, HIIT, pickleball, and more.
○ All-New BioCharge™ Score (Coming soon): A personalized body energy management feature that continuously analyzes energy levels in real time by integrating data from sleep, naps, exertion, and stress helping users balance activity and recovery for better performance.
Helio Strap: Screen-Free, Distraction-Free, Subscription-Free Performance Tracking
Helio Strap is Amazfit’s first screen-free tracker designed to deliver fitness, sleep, and recovery data with exceptional comfort and no distractions. Ideal for athletes of all levels, Helio Strap captures advanced metrics and offers the freedom to train smarter and recover better—all with no subscription required. It pairs seamlessly with Amazfit smartwatches, including Balance 2, Helio Ring, and the Zepp App. ($99.99 USD; €99.9 euro)
Key Features:
○ 10-Day Battery Life: Train, recover, and repeat without missing a beat. The Helio Strap can last up to 10 days from a single charge.
○ Continuous Heart Rate Monitoring: Delivers high-precision heart rate tracking 24/7, enabling users to better understand training load, recovery status, and overall cardiovascular health—all without needing to check a screen or interrupt their routine.
○ 27 Workout Modes accessible through the Zepp App, each tailored to capture key performance metrics and optimize training across a wide range of activities—including running, walking, cycling, and indoor gym workouts like strength training, HIIT, yoga, and more.
○ Strength Training & HYROX Modes: Advanced strength training features with detailed tracking for reps, sets, and rest periods, plus exclusive HYROX Race Mode with race-specific and benchmark training tools.
○ All-New BioCharge™ Score: Available now on Helio Strap, BioCharge is a personalized body energy management feature that continuously analyzes energy levels in real time by integrating data from sleep, naps, exertion, and stress helping users balance activity and recovery for better performance.
“Through a single app, these two devices work seamlessly together—whether it’s during training or recovery monitoring. Each one complements and fills in the gaps of the other, enabling more accurate, cross-referenced data. This means more precise insights for the user, all within one simple, unified system,” said Wayne Huang, CEO of Zepp Health. “With no subscriptions, advanced tracking, and effortless syncing, this duo redefines what wearables can do—whether you’re a competitive athlete or simply striving to be your best.”
Availability and Pricing
The Amazfit Balance 2 smartwatch will be available for $299.99 USD; €299.9 euro, while the Helio Strap will retail for $99.99 USD; €99.9 euro —both launching globally on June 24 via Amazfit.com, Amazon, and select retailers. For users seeking the ultimate performance and recovery solution, the Balance 2 + Helio Strap bundle will be offered at a special price of $379.99 USD.
Please visit https://www.amazfit.com/en/ and follow us on Facebook, Instagram, X (formerly Twitter) and YouTube.
About Amazfit
Amazfit, a leading global smart wearable brand focused on health and fitness, is part of Zepp Health (NYSE: ZEPP), a health technology company with its principal office based in Gorinchem, the Netherlands. Zepp Health operates as a distributed organization, with team members and offices across the Americas, Europe, Asia, and other global markets.
Offering a wide selection of smartwatches and bands, Amazfit's brand tagline, “Discover Amazing,” encourages individuals to break barriers, exceed expectations, and find joy in every moment. Amazfit is powered by Zepp Health’s proprietary health management platform, which delivers cloud-based, 24/7 actionable insights and guidance to help users achieve their wellness goals.
Known for outstanding craftsmanship, Amazfit smartwatches have won numerous design awards, including the iF Design Award and the Red Dot Design Award. Launched in 2015, Amazfit is embraced by millions of users, with products available in over 90 countries across the Americas, EMEA, and APAC regions. For more information, visit www.amazfit.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250624910772/en/
Contacts
Media Contact
Mary Thompson Woodbury
Head of PR, North America
mary.woodbury@zepp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
EADV 2026: Galderma to Unveil New Data Advancing Understanding of Skin Diseases, Skin Longevity, and Real-world Patient Experiences23.9.2026 08:00:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, will present 19 abstracts and deliver a broad scientific education program at the 2026 European Academy of Dermatology and Venereology (EADV) Congress. Through these activities, Galderma will showcase how it continues to advance its pipeline and the science of dermatology, deepening understanding of biological and quality-of-life factors, while driving innovation in targeted treatments, skin longevity and evidence-based care. “At Galderma, we recognize that advancing dermatology means not only addressing the needs of patients living with common chronic skin conditions, such as atopic dermatitis and acne, but also anticipating the trends that will shape the future of skin health. Our presence at EADV demonstrates our unique ability to achieve this, with new data spanning both established areas of unmet need and emerging fields such as skin longevity, helping drive innovation and meaningful outcomes for patients today and i
Oticon Medical Launches SmartCharger for the Ponto 5 Family23.9.2026 08:00:00 EEST | Press release
Oticon Medical today announces the launch of SmartCharger for the Ponto 5 family, introducing its first rechargeable solution for percutaneous sound processors and marking a new step in convenience and portability for bone anchored hearing system users. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922863462/en/ Oticon Medical today announces the launch of SmartCharger for the Ponto 5 family, introducing its first rechargeable solution for percutaneous sound processors and marking a new step in convenience and portability for bone anchored hearing system users. Powering the Ponto 5 family The launch of SmartCharger underlines Oticon Medical’s continued commitment to the Ponto family, which includes Ponto 5 SuperPower, the world’s most powerful abutment-level sound processor,1 and Ponto 5 Mini, the world’s smallest percutaneous sound processor.1 By bringing rechargeable convenience to the Ponto sound processors, Oticon Me
Textron Aviation Marks 500th Cessna Citation Latitude Rollout22.9.2026 17:19:00 EEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced the rollout of the 500th Cessna Citation Latitude business jet from the company’s Wichita, Kansas, manufacturing facility. The production milestone highlights the continued success of the world’s best-selling midsize business jet and recognizes the employees whose craftsmanship and dedication have helped make the Citation Latitude the trusted choice for operators around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922867287/en/ Textron Aviation marks 500th Cessna Citation Latitude rollout. (Photo Credit: Textron Aviation) “The rollout of the 500th Citation Latitude is a testament to the employees who build this aircraft with dedication and pride every day,” said Eric Cardinali, senior vice president, Manufacturing. “Behind every aircraft is a team committed to delivering the quality and craftsmanship our customers expect. This milestone
OCP Announces Date of Second Quarter and First Half 2026 Earnings22.9.2026 17:00:00 EEST | Press release
OCP S.A. (“OCP” or the “Company”), a global leader in the fertilizer industry, will release its second quarter and first half 2026 results on Tuesday, September 29, 2026. The results will be available to holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers on the OCP Intralinks portal from 10:00 a.m. EDT, 2:00 p.m. Morocco (GMT) and 3:00 p.m. London time (GMT+1). OCP senior management will host a conference call to discuss second quarter and first half 2026 results at 11:00 a.m. EDT, 3:00 p.m. Morocco (GMT) and 4:00 p.m. London time (GMT+1) on Tuesday, September 29, 2026, for holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers. Eligible parties that have not already registered for access to the Intralinks portal may do so by contacting the Investor Relations Department by emailing g.laraki@ocpgroup.ma. About OCP OCP is a global leader in the fertilizer industry, backed by almost a century
Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 202622.9.2026 16:30:00 EEST | Press release
Takeda(TSE:4502/NYSE:TAK)announced that new data from its oncology pipeline and portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2026, in Madrid, Spain. Key data will include a late-breaking abstract on arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343*) and two presentations on TAK-928 (Innovent R&D code: IBI363*). Clinical and real-world analyses of ALUNBRIG® (brigatinib) and FRUZAQLA® (fruquintinib) will also be shared at the congress. “Takeda’s data at ESMO reflect our commitment to delivering rapid progress for patients living with some of the most prevalent and challenging cancers, including advanced gastric cancer and immunotherapy-resistant and previously untreated non-small cell lung cancer,” said Phuong Khanh (P.K.) Morrow, M.D., Head of the Oncology Therapeutic Area Unit at Takeda. “Our mission is to advance new therapeutic approaches for patients who need more options or who remain underserved by cur
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom